5. Conclusions
Epicardial transplantation of skeletal myoblasts in conjunction with a CABG or LVAD procedure is feasible and safe, and it does not appear that 116 Edward B. Diethrich cell transplantation poses a substantial risk of life-threatening arrhythmia in this small evaluation. Further study of the efficacy of myoblast transplantation is warranted, and we are now involved in investigations of catheterbased delivery systems and imaging protocols that support percutaneous skeletal myoblast transplantation (as described in “Percutaneous Myoblast Transplantation”, chapter 14 of this text).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
6. References
American Heart Association. AHA Heart and Stroke Statistics-2004 Update.
Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation, Nat. Med. 4, 929–1033 (1998).
Dib N, Diethrich EB, Campbell A, et al. Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction, J. Endovasc. Ther. 9, 313–19 (2002).
Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure, Lancet 357, 279–80 (2001).
Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction, J. Am. Coll. Cardiol. 41, 1078–83 (2003).
Herreros J, Prosper F, Perez A, et al. Autologous intramyocardial injection of cultured skeletal-muscle-derived stem cells in patients with non-acute myocardial infarction, E. Heart J. 24, 2012–20 (2003).
Smits PC, van Geuns RJM, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure, J. Am. Coll. Cardiol. 42, 2063–69 (2003).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Diethrich, E.B. (2006). Skeletal Myoblasts: The U.S. Experience. In: Dib, N., Taylor, D.A., Diethrich, E.B. (eds) Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair. Springer, Boston, MA. https://doi.org/10.1007/0-387-30939-X_7
Download citation
DOI: https://doi.org/10.1007/0-387-30939-X_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25788-4
Online ISBN: 978-0-387-30939-2
eBook Packages: EngineeringEngineering (R0)